Difference between revisions of "Minutes - Referral WG 2023-03-31"

From Health Level 7 Belgium Wiki
(Created page with "=== Attendees === * Anne Nerenhausen * Bart Decuypere * Bart Reekmans * Ben Goosse * Emily Sevrin * Geert Vandenhole * Hans De Keersmaecker * Jean-Michel Polfliet * Julien B...")
 
Line 12: Line 12:
 
* Lionel Cremer
 
* Lionel Cremer
 
* Maarten Cobbaert  
 
* Maarten Cobbaert  
 +
* Marleen Van Eygen
 
* Maxime Daive
 
* Maxime Daive
 
* Philippe Baise
 
* Philippe Baise
Line 28: Line 29:
 
* Katrien Dickx
 
* Katrien Dickx
 
* Laurent Lamouline
 
* Laurent Lamouline
* Marleen Van Eygen
+
 
 
* Pablo Christiaens
 
* Pablo Christiaens
 
* Pieter Devolder
 
* Pieter Devolder
Line 38: Line 39:
 
=== Meeting Minutes ===
 
=== Meeting Minutes ===
 
* [https://github.com/hl7-be/referral/issues/ Issue list]
 
* [https://github.com/hl7-be/referral/issues/ Issue list]
* Feedback from Steering Committee on 7 March:  
+
* There is a new version of the business rules 2.7, [https://github.com/hl7-be/referral/issues/215 see here]
::* [https://github.com/hl7-be/referral/issues/187 Medication issue] : proposal is to ask the prescriber softs tto copy the medication (dose/posology, administration) info in the digital nursing referral prescription
+
* Let's have a look a the newly created issues
::::* but what when the posology changes ? softs are not in favor of this solution (updating - duplicating referrals) as the info would be in the medication scheme
+
* [https://github.com/hl7-be/referral/issues/215 Issue 215: unmapped fields]
::::* we need to list the use cases, Anne will provide this list for review by this WG (link will be added soon)
+
::* a reason code can be added but there is no free text possibility for diagnosis, medical reason
::::* issue is being updated
+
* [https://github.com/hl7-be/referral/issues/214 Issue 214: namespace for identifier]
 
+
::* how to handle the identifiers provided by the clients
::* Route information (how to treat the patient): a value set has been defined - where will this be put in the referral prescription ?
+
::* still under investigation
::* Annex 81: waiting for use cases
+
* [https://github.com/hl7-be/referral/issues/216 Issue 216: can we add the name/version of the client software in the metadata of the resource]
 
+
::* as a help when issues occurs for support reason
::* [https://github.com/hl7-be/referral/issues/77 Wound care] : list bodyparts has been screened, update will be given next week
+
::* can the contact info added in the user agent be useful ? are the requirements for the user agent available at eHealth platform ? afterwards, investigate if this would be sufficient
::* [https://github.com/hl7-be/referral/issues/169 Issue 169] : meeting RIZIV/CIN is next Tuesday, update will be given next week
+
::* can the provenance resource be used ? would make it complicated
::* [https://github.com/hl7-be/referral/issues/5 Issue 5]: mapping proposal is being presented by Bart
+
::* has to be investigated
::::* link between logical model and profiles, [https://build.fhir.org/ig/hl7-be/referral/mapping.html see here]  
+
* [https://github.com/hl7-be/referral/issues/213 Issue 213: inconsistencies body location]
::::::* principle looks OK for the WG, to be completed for request group model and subtype of nursing referral prescription
+
::* on top is the schema is in the business rules, below is the list of the snomed codes
 +
::* it will be looked into by RIZIV internally (Katrien + Anne)
 +
::* for wound care there are the same issues (see issue) : is being worked on by RIZIV internally
 +
* [https://github.com/hl7-be/referral/issues/211 Issue 211: useCase CoSign]
 +
::* results of the exercise can be looked into in the IG: https://build.fhir.org/ig/hl7-be/referral/ServiceRequest-ucgh211-1.html
 +
::* will not be part of Release1
 +
* [https://github.com/hl7-be/referral/issues/210 Issue 210: compression therapy]
 +
::* RIZIV is investigating
 +
* [https://github.com/hl7-be/referral/issues/191 Issue 191: versioning]
 +
::* RIZIV and eHealth platform need to sync
  
 
::* Annex 81 use case : work awaits steerco decision
 
::* Annex 81 use case : work awaits steerco decision
Line 59: Line 69:
  
 
* Progress on use cases : none due to  
 
* Progress on use cases : none due to  
::* forannex 81 still awaiting info
+
::* for annex 81 still awaiting info
 
::* multiple prescribers : still under investigation
 
::* multiple prescribers : still under investigation
  

Revision as of 07:28, 31 March 2023

Attendees

  • Anne Nerenhausen
  • Bart Decuypere
  • Bart Reekmans
  • Ben Goosse
  • Emily Sevrin
  • Geert Vandenhole
  • Hans De Keersmaecker
  • Jean-Michel Polfliet
  • Julien Beard
  • Karlien Erauw
  • Lionel Cremer
  • Maarten Cobbaert
  • Marleen Van Eygen
  • Maxime Daive
  • Philippe Baise
  • Robin Merckx

Excused

  • Anthony Maton
  • Benjamien Schmitt
  • Christophe Behaegel
  • Cyprien Janssens
  • Dorsan de Fabricheckers
  • Jacques Yakoub
  • Jean-Francois Coquelet
  • José Costa Teixeira
  • Katleen Smedts
  • Katrien Dickx
  • Laurent Lamouline
  • Pablo Christiaens
  • Pieter Devolder
  • Richard Francken

Agenda

  • Resolution of issues

Meeting Minutes

  • a reason code can be added but there is no free text possibility for diagnosis, medical reason
  • how to handle the identifiers provided by the clients
  • still under investigation
  • as a help when issues occurs for support reason
  • can the contact info added in the user agent be useful ? are the requirements for the user agent available at eHealth platform ? afterwards, investigate if this would be sufficient
  • can the provenance resource be used ? would make it complicated
  • has to be investigated
  • on top is the schema is in the business rules, below is the list of the snomed codes
  • it will be looked into by RIZIV internally (Katrien + Anne)
  • for wound care there are the same issues (see issue) : is being worked on by RIZIV internally
  • RIZIV is investigating
  • RIZIV and eHealth platform need to sync
  • Annex 81 use case : work awaits steerco decision
  • Issue 10: José is checking with Anthony and at transversal level
  • Issue 126: needs to be checked by RIZIV, linked to use case multiple prescribers
  • still being investigated
  • Progress on use cases : none due to
  • for annex 81 still awaiting info
  • multiple prescribers : still under investigation

Agenda next meeting

  • feedback on use cases
  • input on issues to continue resolution of issues : we will have to assess upfront if we have sufficient additional input by next Friday to be able to have an efficient meeting or not

Next meeting: next week Friday 14 April at 9AM